U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Medical Devices
  3. Device Advice: Comprehensive Regulatory Assistance
  4. Guidance Documents (Medical Devices and Radiation-Emitting Products)
  5. Guidance on the Department of Defense Exemption from the FDA Performance Standard for Laser Products (Laser Notice No. 52)
  1. Guidance Documents (Medical Devices and Radiation-Emitting Products)

Guidance on the Department of Defense Exemption from the FDA Performance Standard for Laser Products (Laser Notice No. 52)

PDF Printer Version
(243 KB)

Guidance on the Department of Defense Exemption from the FDA Performance Standard for Laser Products; Guidance for Industry and FDA

(Laser Notice No. 52)

Document issued on: July 12, 2002

CDRH Logo

U.S. Department of Health and Human Services
Food and Drug Administration
Center for Devices and Radiological Health

Electronic Product Devices Branch
Division of Enforcement III
Office of Compliance

Preface

Public Comment

Comments and suggestions may be submitted at any time for Agency consideration to Dockets Management Branch, Division of Management Systems and Policy, Office of Human Resources and Management Services, Food and Drug Administration, 5630 Fishers Lane, Room 1061, (HFA-305), Rockville, MD, 20852. When submitting comments, please refer to the exact title of this guidance document. Comments may not be acted upon by the Agency until the document is next revised or updated.

For questions regarding the use or interpretation of this guidance contact Dan Hewett at 301-796-5864, or daniel.hewett@fda.hhs.gov.

Additional Copies

Additional copies are available from the Internet. You may also send an e-mail request to CDRH-Guidance@fda.hhs.gov to receive a copy of the guidance. Please use the document number (1412) to identify the guidance you are requesting.

Guidance on the Department of Defense Exemption from the FDA Performance Standard for Laser Products (Laser Notice No. 52)

This document is intended to provide guidance. It represents the Agency's current thinking on this topic. It does not create or confer any rights for or on any person and does not operate to bind the Food and Drug Administration (FDA) or the public. An alternative approach may be used if such approach satisfies the requirements of the applicable statute and regulations.

Purpose

This guidance clarifies and updates the conditions of FDA exemption no. 76EL-01DOD granted in 1976 to the U.S. Department of Defense (DoD) for laser products procured for combat or combat training or that are classified for reasons of national security. This guidance supplements Laser Notice Nos. 9 and 15 and identifies the current resources in the military services for the administration of this exemption.

Issue

The U.S. Department of Defense established a joint services group, the Laser Systems Safety Working Group (LSSWG), to coordinate laser safety issues within the DoD. The LSSWG requested FDA to reissue its earlier guidance to industry on the subject of the DoD exemption. The LSSWG request was based on a concern that laser products not in compliance with the FDA standard are offered to various DoD purchasing authorities and procured without appropriate control measures implemented to assure the safest possible use.

Background

Laser products sold in or imported into the United States must comply with the Federal Performance Standard for Laser Products issued by the Food and Drug Administration (FDA), Center for Devices and Radiological Health (CDRH), in Title 21, Code of Federal Regulations, Subchapter J, Parts 1040.10 and 1040.11 (1). The Federal Laser Standards require laser products to incorporate certain safety features, which may include warning lights, warning labels, and housing interlocks.

In 1976, the FDA Commissioner allowed the Department of Defense (DoD) or its components to exempt certain military laser products from the provisions of the Federal Laser Standard and associated reporting and recordkeeping requirements. This exemption applies to DoD lasers used for actual combat or combat training or those classified in the interest of national security. The exemption was granted with the following provisions:

  • Laser product specifications must include, to the extent practicable, the safety features required by the FDA standard;
  • Laser product specifications will be supplemented with safety controls specified by DoD; and
  • DoD exempted laser products will be clearly identified through labeling.

An example of how the DoD exemption may be applied is to exempt a military laser product from the FDA requirements for laser radiation emission indicators and warning labels. These visible or audible emission indicators and brightly-colored labeling are inappropriate for products intended for use in a combat environment where camouflage and concealment are necessary.

The Least Burdensome Approach

The issues identified in this guidance document represent those we believe need to be addressed before your product can be marketed. In developing the guidance, we carefully considered the relevant statutory criteria for Agency decision-making. We also considered the burden that may be incurred in your attempt to comply with the guidance and address the issues we have identified. We believe that we have considered the least burdensome approach to resolving the issues presented in the guidance document. If, however, you believe that there is a less burdensome way to address the issues, you should follow the procedures outlined in the "A Suggested Approach to Resolving Least Burdensome Issues" document (Withdrawn).

Guidance

The manufacturer must obtain an exemption letter from an authorized DoD procuring agency to allow the use of the DoD exemption for a specific product. The manufacturer must obtain the DoD exemption letter prior to sale and retain it for subsequent sales to any DoD agency. Any subsequent modification to a "military exempt" laser product by the manufacturer requires a new DoD exemption letter. The DoD exemption letter may specify a number of units, an armed service, and/or a period of time.

A manufacturer violates Federal law if it sells a laser system not in compliance with the FDA standard to the DoD or falsely labels a laser product as exempt without a written DoD exemption letter. Several laser system manufacturers market laser products that are labeled as "military exempt." Many of these systems lack written documentation of DoD exemption. An appropriate DoD laser safety representative must evaluate all "military exempt" laser products to determine compliance with relevant military or Federal requirements. Manufacturers of "military exempt" laser products should not assume the DoD exemption applies to its product unless DoD provides an exemption letter.

Once the DoD exemption is applied to a specific laser system, the system cannot be sold, surplused, or distributed to organizations outside the DoD, unless the laser system is brought into full compliance with the FDA standard, certified, and reported in accordance with FDA regulations.

For further information on this process, contact an appropriate DoD laser safety representative.

US Army Institute of Public Health
ATTN: MCHB-IP-OLO
Occupational Health Sciences Portfolio
Aberdeen Proving ground, Maryland 21010-5403
(410) 436-3932

Commander, Naval Surface Warfare Center Dahlgren Division
17320 Dahlgren Road
Dahlgren, VA 22448-5100
(540) 653-1149

Air Force Research Laboratory
Human Effectiveness Directorate; Optical Radiation Branch
711 HPW/RHDO
4141 Petroleum Rd
Fort Sam Houston, TX 78234Phone: (210) 539-2375
Email: 711HPW.RHDO.USAFLaserSafety@us.af.mil

Getting More Information
You can get more information about our requirements for lasers from our electronic product radiation control web page.

If you have questions about this guidance, contact Dan Hewett, CDRH, Office of Communication, Education and Radiation Programs, 10903 New Hampshire Avenue, Silver Spring, MD 20993 or daniel.hewett@fda.hhs.gov.

Phillip J. Frappaolo
Acting Director
Office of Compliance
Center for Devices and Radiological Health


(1) See 21 CFR 1040.10 (a) for details on the applicability of the FDA standard and exceptions from applicability.

Back to Top